| Denomination of resistotypes | Drug resistance pattern | No. of isolate (%) |
| PR1 | A,B,OX,VA,R,AM,CD,SZ,E | 3(6.38%) |
| PR2 | A,B,OX,VA,R,AM,CD,SZ,E,AC | 4(8.51%) |
| PR3 | A,B,OX,VA,R,AM,CD,SZ,E,AC,PB | 3(6.38%) |
| PR4 | A,B,OX,VA,R,AM,CD,SZ,E,PB | 8(17.02%) |
| PR5 | A,B,OX,VA,R,AM,CD,SZ,AC,PB | 1(2.12%) |
| PR6 | A,B,OX,VA,R,AM,CD,SZ,E,CH | 1(2.12%) |
| PR7 | A,B,OX,VA,R,AM,CD,SZ,E,PB,TR | 1(2.12%) |
| PR8 | A,B,OX,VA,R,AM,CD,SZ,PB | 2(4.25%) |
| PR9 | A,B,OX,VA,R,AM,CD,SZ,E,AC,CH,TR | 1(2.12%) |
| PR10 | A,B,OX,VA,R,AM,CD,SZ,E,PB,CH,TR | 1(2.12%) |
| PR11 | A,B,OX,VA,R,AM,CD,SZ,E,AC,PB,T | 1(2.12%) |
| PR12 | A,B,OX,VA,R,AM,CD,SZ,E,AC,PB,TR | 1(2.12%) |
| PR13 | A,B,OX,VA,R,AM,CD,SZ,E,AC,PB,CA | 1(2.12%) |
| PR14 | A,B,OX,VA,R,AM,CD,SZ,E,AC,T | 1(2.12%) |
| PR15 | A,B,OX,VA,R,AM,CD,SZ,E,PB,TR,CF | 1(2.12%) |
| PR16 | A,B,OX,VA,R,AM,CD,SZ,E,AC,CH,CF | 1(2.12%) |
| PR17 | A,B,OX,VA,R,AM,CD,SZ,E,AC,TR,CF | 1(2.12%) |
| PR18 | A,B,OX,VA,R,AM,CD,SZ,E,TR | 2(4.25%) |
| PR19 | A,B,OX,VA,R,AM,CD,SZ,AC | 1(2.12%) |
| PR20 | A,B,OX,VA,R,AM,CD,SZ,E,CF | 1(2.12%) |
| PR21 | A,B,OX,VA,R,AM,CD,SZ,E,AC,NX | 1(2.12%) |
| PR22 | A,B,OX,VA,R,AM,CD,SZ,E,CH,TR,CA | 1(2.12%) |
| PR23 | A,B,OX,VA,R,AM,CD,SZ,E,AC,NX,K | 1(2.12%) |
| PR24 | A,B,OX,VA,R,AM,CD,SZ,PB,FAH | 1(2.12%) |
| PR25 | A,B,OX,VA,R,AM,CD,SZ,E,AC,CH,T,FAH | 1(2.12%) |
| PR26 | A,B,OX,VA,R,AM,CD,SZ,E,PB,FAH | 1(2.12%) |
| PR27 | A,B,OX,VA,R,AM,CD,SZ,E,AC,PB,CH,TR,T,CPM,CE, | 1(2.12%) |
| PR28 | A,B,OX,VA,R,AM,CD,SZ,AC,PB,CH,TR,T,CA,CPM,CE | 1(2.12%) |
| PR29 | A,B,OX,VA,R,AM,CD,SZ,AC,CH,TR,T,CA,NX,K,CPM,CE, | 1(2.12%) |
| PR30 | A,B,OX,VA,R,AM,CD,SZ,E,AC,PB,CH,TR,T,CA,NX,K,CPM,CE | 1(2.12%) |
| PR31 | A,B,OX,VA,R,AM,CD,SZ,E,AC,PB,CH,TR,T,CA,K,AS,CPM,CE | 1(2.12%) |